US Broker Ratings

Butterfly Network, Inc. (BFLY): Investor Outlook on a Potential 94% Upside in the Medical Devices Sector

Butterfly Network, Inc. (NASDAQ: BFLY), a pioneer in the medical devices sector, is garnering significant attention from investors, driven by its innovative approach to ultrasound imaging...

iRadimed Corporation (IRMD) Stock Analysis: A Healthcare Innovator with 23.75% ROE and Promising Growth

iRadimed Corporation (NASDAQ: IRMD), a key player in the medical devices sector, has captured the attention of investors with its impressive return on equity (ROE) of..

Syndax Pharmaceuticals, Inc. (SNDX): Analyst Ratings Point to 122.82% Potential Upside

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a key player in the biopharmaceutical domain, stands at a unique crossroads in the healthcare sector, specifically within the biotechnology industry...

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Potential 185.71% Upside Captivates Investor Attention

Trevi Therapeutics, Inc. (NASDAQ: TRVI) emerges as a compelling opportunity in the biotechnology sector, offering investors a potential upside of 185.71%. With its focus on developing..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Unveiling a 22.52% Potential Upside in the Biotech Arena

Stoke Therapeutics, Inc. (NASDAQ: STOK) is steadily gaining traction in the biotechnology arena, captivating investors with its innovative approach to genetic diseases and a promising market..

Avadel Pharmaceuticals plc (AVDL) Investor Outlook: Exploring a Promising 30% Potential Upside

For investors keeping a keen eye on the healthcare sector, Avadel Pharmaceuticals plc (NASDAQ: AVDL) offers a compelling proposition with its significant growth potential. The company,..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Exploring a Potential 13.92% Upside for Investors

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) stands out as an intriguing opportunity within the biotechnology sector, especially for investors eyeing potential upside in the healthcare space...

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring the 206% Potential Upside

Taysha Gene Therapies, Inc. (TSHA), a clinical-stage biotechnology company, is capturing attention with its ambitious focus on adeno-associated virus-based gene therapies targeting monogenic diseases of the..

Valneva SE (VALN) Stock Analysis: Promising Upside with 54.69% Growth Potential

Valneva SE (VALN), a French biotechnology company specializing in the development and commercialization of prophylactic vaccines, is currently capturing investor attention with its potential for significant..

Bioventus Inc. (BVS) Stock Analysis: Unveiling a 75% Potential Upside in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS), a key player in the healthcare sector with a focus on medical devices, presents a compelling investment opportunity for those looking to..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring a High Potential Upside of 52.37%

AxoGen, Inc. (NASDAQ: AXGN) stands out in the healthcare sector, specifically within the medical devices industry, as a company that is pioneering the development and commercialization..

Personalis, Inc. (PSNL) Stock Analysis: A Look at Its 47.75% Potential Upside

For investors keen on exploring the diagnostic and research landscape within the healthcare sector, Personalis, Inc. (NASDAQ: PSNL) offers a compelling opportunity. With a market capitalization..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Biotech Gem with a 94% Potential Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO) stands out in the biotechnology sector, not only for its innovative approach to immunology-based therapies but also for the significant upside..

Replimune Group, Inc. (REPL) Stock Analysis: Navigating Biotech with a 9.72% Potential Downside

Replimune Group, Inc. (NASDAQ: REPL) stands out in the competitive biotechnology sector as a clinical-stage company focused on pioneering oncolytic immunotherapies to combat cancer. Based in..

ArriVent BioPharma (AVBP) Investor Outlook: Analysts Predict a Potential 105.91% Upside

ArriVent BioPharma, Inc. (AVBP) is drawing significant attention in the biotechnology sector, primarily due to its promising pipeline and the optimistic outlook from analysts. With a..

CureVac N.V. (CVAC) Stock Analysis: Navigating the mRNA Frontier with Strategic Developments

CureVac N.V. (NASDAQ: CVAC) is a prominent player in the biotechnology industry, with a focus on developing transformative medicines based on messenger RNA (mRNA) technology. Headquartered..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring a Potential 18% Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find Enhabit, Inc. (NASDAQ: EHAB) an intriguing prospect. With its focus on home health and hospice services, Enhabit..

MeiraGTx Holdings plc (MGTX): Unveiling a Potential 264.93% Upside in Biotechnology

Investors with an eye on the biotechnology sector should pay close attention to MeiraGTx Holdings plc (NASDAQ: MGTX), a clinical-stage gene therapy company that is creating..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 99% Upside Potential in Telehealth Innovation

LifeMD, Inc. (LFMD) is carving a niche in the burgeoning telehealth sector, presenting a compelling opportunity for investors focused on healthcare innovation. Operating in the health..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a Potential 156.85% Upside in the Biotech Sector

Nuvation Bio Inc. (NASDAQ: NUVB) is making waves in the biotechnology sector with its promising pipeline of oncology-focused therapeutic candidates. Despite its current stock price of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds